Hotspot Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2017-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.hotspotthera.com
Clinical Trials
3
Active:2
Completed:1
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (66.7%)phase_1_2
1 (33.3%)A Study of HST-1011 Given as Monotherapy and in Combination With an Anti-PD1 Antibody
Phase 1
Active, not recruiting
- Conditions
- Solid Tumor, AdultRefractory CancerRelapsed Cancer
- Interventions
- First Posted Date
- 2022-12-22
- Last Posted Date
- 2025-02-04
- Lead Sponsor
- HotSpot Therapeutics, Inc
- Target Recruit Count
- 77
- Registration Number
- NCT05662397
- Locations
- 🇺🇸
Florida Cancer Specialists, Sarasota, Florida, United States
🇺🇸Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, United States
🇺🇸Montefiore Einstein Comprehensive Cancer Center, Bronx, New York, United States
News
No news found